TrialHuman vaccines & immunotherapeutics2014

Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized open-label trial.

Christine Juergens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.